Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valentus Global was a direct selling and wellness lifestyle company offering nutritional supplements and related health products, with most sales in Europe and North America. The business was acquired by Zinzino in April 2025 for SEK 20 million after reporting over SEK 50 million in annual sales. There is no public clinical data as the company's offerings are not regulated pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valentus Global.